SEC Form 4 · accession 0001144204-16-138422
Cytosorbents Corp · CTSO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kathleen P. Bloch
Officer — Chief Financial Officer
Period of report
Dec 6, 2016
Accepted (ET)
Dec 7, 2016 · 5:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175151
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 6, 2016 | P | 1,000 | $4.8292 | A | 8,000 | I | See Footnote |
| Common Stock | holding | — | — | — | 122,325 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are held by the reporting person's husband in a 401(k) account, and as such, the reporting person may be deemed the beneficial owner of such shares.